NAVIDEA BIOPHARMACEUTICALS, INC. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Mar 30, 2015
Insider Transaction Report
Form 4
Regan William J.
SVP of lobal Regulatory Strate
Transactions
- Award
Common Stock (Right to Buy)
2015-03-26+165,000→ 165,000 totalExercise: $1.65Exp: 2025-03-26→ Common Stock (165,000 underlying)
Footnotes (1)
- [F1]Option vests 25% per year beginning on the first anniversary of the date of grant.